Logo image of HKIT

HITEK GLOBAL INC-CL A (HKIT) Stock Fundamental Analysis

USA - NASDAQ:HKIT - KYG451391059 - Common Stock

1.675 USD
-0.09 (-5.37%)
Last: 9/17/2025, 1:34:40 PM
Fundamental Rating

2

Overall HKIT gets a fundamental rating of 2 out of 10. We evaluated HKIT against 86 industry peers in the IT Services industry. The financial health of HKIT is average, but there are quite some concerns on its profitability. HKIT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year HKIT has reported negative net income.
HKIT had a negative operating cash flow in the past year.
Of the past 5 years HKIT 4 years were profitable.
In multiple years HKIT reported negative operating cash flow during the last 5 years.
HKIT Yearly Net Income VS EBIT VS OCF VS FCFHKIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M

1.2 Ratios

HKIT has a worse Return On Assets (-1.87%) than 60.47% of its industry peers.
HKIT has a Return On Equity of -2.20%. This is comparable to the rest of the industry: HKIT outperforms 44.19% of its industry peers.
Industry RankSector Rank
ROA -1.87%
ROE -2.2%
ROIC N/A
ROA(3y)2.5%
ROA(5y)5.79%
ROE(3y)3.88%
ROE(5y)7.9%
ROIC(3y)N/A
ROIC(5y)N/A
HKIT Yearly ROA, ROE, ROICHKIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Gross Margin, with a value of 41.35%, HKIT is in the better half of the industry, outperforming 60.47% of the companies in the same industry.
HKIT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HKIT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.77%
GM growth 5Y-8.54%
HKIT Yearly Profit, Operating, Gross MarginsHKIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

6

2. Health

2.1 Basic Checks

HKIT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HKIT has more shares outstanding
The number of shares outstanding for HKIT has been increased compared to 5 years ago.
HKIT has a better debt/assets ratio than last year.
HKIT Yearly Shares OutstandingHKIT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
HKIT Yearly Total Debt VS Total AssetsHKIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

HKIT has an Altman-Z score of 6.20. This indicates that HKIT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.20, HKIT belongs to the best of the industry, outperforming 80.23% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that HKIT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, HKIT is in the better half of the industry, outperforming 72.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 6.2
ROIC/WACCN/A
WACC7.86%
HKIT Yearly LT Debt VS Equity VS FCFHKIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

HKIT has a Current Ratio of 13.08. This indicates that HKIT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HKIT (13.08) is better than 100.00% of its industry peers.
HKIT has a Quick Ratio of 13.02. This indicates that HKIT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HKIT (13.02) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 13.08
Quick Ratio 13.02
HKIT Yearly Current Assets VS Current LiabilitesHKIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

HKIT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.94%.
The Revenue for HKIT has decreased by -36.92% in the past year. This is quite bad
The Revenue for HKIT have been decreasing by -15.96% on average. This is quite bad
EPS 1Y (TTM)-126.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.06%
Revenue 1Y (TTM)-36.92%
Revenue growth 3Y-23.39%
Revenue growth 5Y-15.96%
Sales Q2Q%-36.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HKIT Yearly Revenue VS EstimatesHKIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HKIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HKIT Price Earnings VS Forward Price EarningsHKIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HKIT Per share dataHKIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HKIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HITEK GLOBAL INC-CL A

NASDAQ:HKIT (9/17/2025, 1:34:40 PM)

1.675

-0.09 (-5.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)10-16 2025-10-16
Inst Owners0.25%
Inst Owner Change17.21%
Ins Owners8.07%
Ins Owner ChangeN/A
Market Cap49.08M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.36
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.16
BVpS1.2
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.87%
ROE -2.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.35%
FCFM N/A
ROA(3y)2.5%
ROA(5y)5.79%
ROE(3y)3.88%
ROE(5y)7.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.77%
GM growth 5Y-8.54%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.08
Quick Ratio 13.02
Altman-Z 6.2
F-Score3
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.92%
Revenue growth 3Y-23.39%
Revenue growth 5Y-15.96%
Sales Q2Q%-36.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-448.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-177.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1012.28%
OCF growth 3YN/A
OCF growth 5YN/A